Drug Topics

DECEMBER 20, 2024

Recent upticks of the bird flu virus in both dairy cattle and humans have also led to a state of emergency in California.

468

468

STAT

DECEMBER 18, 2024

James Mannion knew what he needed. For nine months, while incarcerated in a county jail in Portland, Maine, he pleaded for a medication called buprenorphine. Mannion, a barber, recreational fisherman, and father of two, was once a regular heroin user, but had used the medication to eliminate the cravings and withdrawal he experienced whenever he tried to quit opioids cold turkey.

141

141

The Checkup by Singlecare

DECEMBER 18, 2024

Zyrtec ( cetirizine ) is an over-the-counter ( OTC ) medication and antihistamine used to treat allergy symptoms. Signs of allergic rhinitis, hay fever , and seasonal allergies include sneezing , runny nose , stuffy nose , swollen nasal passages , itchy eyes , and watery eyes. These conditions are similar to nonallergic rhinitis in that they cause the same symptoms, but they are different in that the latter isnt caused by contact with an allergen.

Dosage 105

Dosage Immunization 105

PharmaVoice

DECEMBER 17, 2024

Bluejay Therapeutics is one of just a handful of companies developing treatments for hepatitis D.

278

278

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

Drug Topics

DECEMBER 20, 2024

With pressure from the House GOP, expected PBM reform was not included in Congress end-of-year spending package.

Packaging 551

Packaging 551

STAT

DECEMBER 20, 2024

Novo Nordisk’s next-generation obesity candidate led patients to lose a substantial amount of weight in a pivotal study but fell short of expectations, results that cast into doubt the future competitiveness of the company in the booming weight loss market. The treatment, called CagriSema, led patients to lose 20% of their weight at 68 weeks in a late-stage study when looking at all participants, including those who dropped out, Novo said Friday.

140

140

PharmaVoice

DECEMBER 19, 2024

A new antibody from Merck would join a market teeming with new entries, but plenty of regulatory and financial uncertainty.

245

245

Drug Topics

DECEMBER 18, 2024

The American Pharmacists Association announced the inclusion of pharmacist-backed PBM reform in Congress end of the year spending package.

Packaging 503

Packaging 503

STAT

DECEMBER 19, 2024

Most of the formularies run by some of the largest health plans in the U.S. generally provide “fair access” to 11 treatments for several serious diseases, although transparent coverage information is often lacking for some medicines, a new analysis has found. Almost uniformly, the 11 formularies made the drugs available fairly when judged on three criteria: eligibility based on clinical data, restrictions placed on prescribers, and step therapy, which requires patients to try other

Department of Veterans Affairs 120

Department of Veterans Affairs Insurance 120

The Checkup by Singlecare

DECEMBER 17, 2024

Like semaglutide, Mounjaro (tirzepatide) is a once-a-week injectable medication that is FDA approved for helping manage blood sugar levels in those with Type 2 diabetes. It mimics two gastrointestinal hormones: glucagon-like peptide-1 (GLP-1) and gastric inhibitory polypeptide (GIP). So, the active ingredient can also be prescribed for weight loss or obesity, combined with diet and exercise, under its licensed brand name Zepbound.

Packaging 98

Packaging FDA 98

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

PharmaVoice

DECEMBER 18, 2024

The pharma giant is looking for another edge in the competitive weight loss market through DTC expansion.

231

231

Drug Topics

DECEMBER 20, 2024

Zepbound from Eli Lilly is the first and only prescription medicine approved by the FDA for adults with obstructive sleep apnea and obesity.

FDA 467

FDA 467

STAT

DECEMBER 19, 2024

The Food and Drug Administration on Thursday confirmed that a shortage of Eli Lilly’s obesity drug tirzepatide has been resolved, a move that will soon put a stop to companies making cheaper copies of the injection. The agency said it would give these compounders a grace period of 60 to 90 days before enforcing rules that would put a halt to their work, in an effort to avoid disruption for patients.

Compounding 131

Compounding FDA Compounding Pharmacies 131

The Checkup by Singlecare

DECEMBER 19, 2024

Tens of millions of people start their day with coffee without a second thoughtmany even find it difficult to have any thoughts at all before their first cup. But if youre taking prescription drugs on a regular basis, such as Linzess (the brand name for linaclotide), you may be wondering if you need to rethink your morning joe. Linzess is an oral medication that is approved by the Food and Drug Administration for the treatment of irritable bowel syndrome with constipation (IBS-C) as well as chro

95

95

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

Fierce Pharma

DECEMBER 19, 2024

The FDA has doubled down on its decision to remove Eli Lillys tirzepatide from its list of products that are in shortage. | The FDA has doubled down on its decision to remove Eli Lillys tirzepatide from its list of products that are in shortage. The agencys move means that compounding pharmacies will have to halt production of their knockoff versions of diabetes drug Mounjaro and obesity treatment Zepbound.

Compounding Pharmacies 100

Compounding Pharmacies FDA Compounding 100

Drug Topics

DECEMBER 20, 2024

Authors concluded that that the benefit of the vaccine in preventing long COVID is due mainly to the fact it mitigates the risk of infection.

Vaccines 456

Vaccines 456

STAT

DECEMBER 19, 2024

CVS Health was accused of contributing to a nationwide epidemic of opioid addiction and overdose by filling illegal opioid prescriptions and billing federal health insurance programs, according to a lawsuit unsealed Wednesday by the U.S. Department of Justice. The lawsuit alleged that, since October 2013, CVS knowingly filled prescriptions for “dangerous and excessive quantities” of controlled substances that lacked a legitimate medical purpose, were not valid, and were not issued

Controlled Substances 109

Controlled Substances Insurance 109

The Checkup by Singlecare

DECEMBER 16, 2024

Theres nothing like biting into a sun-kissed orange, its juice filling your mouth with the refreshing taste of citrus. But if youre a person living with diabetes , you may wonder what effect the sweet treat will have on your blood sugar. You probably know that managing your blood sugar levels means being mindful of your carbohydrate intake and the glycemic index of your foods.

Immunization 98

Immunization Hospitals 98

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

PharmaVoice

DECEMBER 20, 2024

The high drama of an election year, industry layoffs, patent cliff strategies and other key trends that shaped pharma in 2024.

147

147

Drug Topics

DECEMBER 17, 2024

Treatment of comorbidities may help patients overcome resistance or refractoriness to migraine therapies.

446

446

STAT

DECEMBER 20, 2024

And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda is still shaping up, but we do foresee a few developments, such as promenading the official mascots, hanging with one of our short people, and escorting Mrs. Pharmalot to a house party or two.

Compounding 113

Compounding FDA 113

Pharmacy Times

DECEMBER 20, 2024

New mechanisms of action are proving more effective than ever, offering slowed progression.

145

145

Hospital Pharmacy Europe

DECEMBER 17, 2024

S erious adverse drug events are unfortunately common in hospitals and can occur across all stages of the medication delivery process. Here, Francine de Stoppelaar shares her top tips for implementing effective closed loop medicines management systems as part of a hospitals digital transformation journey to enhance patient care, reduce expenditures and build a sustainable future for healthcare.

Hospitals 52

Hospitals Patient Care Medication Delivery Documentation 52

Drug Topics

DECEMBER 19, 2024

The lawsuit alleges that the company knowingly violated both the Controlled Substances Act and the False Claims Act.

Controlled Substances 359

Controlled Substances 359

STAT

DECEMBER 19, 2024

Top of the morning to you, and a fine one it is. Clear blue skies and chilly breezes are wafting across the Pharmalot campus, where the official mascots are snoozing after foraging for their breakfast. This means we are free to focus on the matters at hand — rummaging through our to-do list and making cups of stimulation. Our choice today is blueberry cobbler.

Department of Veterans Affairs 100

Department of Veterans Affairs Insurance 100

Fierce Healthcare

DECEMBER 18, 2024

It still needs to pass, but an end-of-year package for healthcare is looking probable. The legislation includes PBM reform, telehealth extensions and more.

Packaging 140

Packaging 140

Pharmacy Times

DECEMBER 20, 2024

The findings show a need for researchers and health care professionals to consider model designs to minimize disparities when diagnosing perinatal mood and anxiety disorders (PMADs).

139

139

Drug Topics

DECEMBER 18, 2024

MannKind announced results from the INHALE-1 study that examined Afrezza in children and adolescents with diabetes.

357

357

STAT

DECEMBER 18, 2024

Hello, everyone, and how are you today? We are doing just fine, thank you, especially since the middle of the week is upon us. After all, we have made it this far so we are determined to hang on for another couple of days. And why not? The alternatives — at least those we can identify — are not so appetizing. And what better way to make the time fly than to keep busy.

FDA 108

FDA 108

Fierce Healthcare

DECEMBER 19, 2024

The Justice Department has filed suit against CVS, alleging that the retail giant unlawfully dispensed opioid prescriptions. | The Justice Department has filed suit against CVS, alleging that the retail giant unlawfully dispensed opioid prescriptions.

135

135

Pharmacy Times

DECEMBER 20, 2024

Compounding pharmacies have a 60- to 90-day grace period to complete production as it continues to monitor supply and demand.

Compounding 139

Compounding Compounding Pharmacies FDA 139

Drug Topics

DECEMBER 18, 2024

Chelsee Jensen, PharmD, BCPS, senior pharmacy specialist at the Mayo Clinic, discusses her career and how biosimilars will impact the pharmacy profession in the coming years.

Mayo Clinic 355

Mayo Clinic 355

STAT

DECEMBER 17, 2024

You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine.  Sign up here  to receive it in your inbox on Tuesdays and Thursdays. Congress nears spending deal with long-awaited PBM reforms Congress is on the edge of a deal that would reshape pharmacy benefit managers, extend telehealth access, and renew certain public health authorities.

Packaging 98

Packaging FDA Insurance 98